7 Molecular Diagnostics Recent Developments 7.1 Recent Developments - Importance and How to Use This Section 7.1.1 Importance of These Developments 7.1.2 How to Use This Section 7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx 7.3 Invitae to Acquire Genosity for $200M 7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test 7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience 7.6 Natera Revenues Grow 35 Percent 7.7 AnchorDx Closes $40M Financing Round 7.8 Exact Sciences Strategy for End-to-End Cancer Testing 7.9 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch 7.10 Singlera Genomics Closes $150M Funding for Cancer Screening 7.11 Biocartis GeneproDx, Endpoint Health Collaborate on Tests for Idylla Platform